Switzerland's NOVARTIS (23.7 bn CHF turnover in first nine months of 2001) is planning to sell off its nutrition division in the next six to twelve months that includes brands like Ovomaltine, Cereal and Isostar. The division currently has an annual turnover of 850 million CHF (around EUR 566 million), accounting for between 2 and 3% of NOVARTIS' total sales. The sale should net between EUR 740 million and EUR 1.3 bn.